Ono Pharmaceutical Management
Management criteria checks 3/4
Ono Pharmaceutical's CEO is Gyo Sagara, appointed in Sep 2008, has a tenure of 16.17 years. total yearly compensation is ¥190.00M, comprised of 41.1% salary and 58.9% bonuses, including company stock and options. directly owns 0.026% of the company’s shares, worth ¥206.06M. The average tenure of the management team and the board of directors is 1.8 years and 4.4 years respectively.
Key information
Gyo Sagara
Chief executive officer
JP¥190.0m
Total compensation
| CEO salary percentage | 41.1% |
| CEO tenure | 16.2yrs |
| CEO ownership | 0.03% |
| Management average tenure | 1.8yrs |
| Board average tenure | 4.4yrs |
Recent management updates
Recent updates
Is Ono Pharmaceutical (TSE:4528) A Risky Investment?
Nov 25
Ono Pharmaceutical Co., Ltd. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Nov 03We Think Ono Pharmaceutical (TSE:4528) Can Stay On Top Of Its Debt
Aug 25Ono Pharmaceutical Co., Ltd. (TSE:4528) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Aug 04There's No Escaping Ono Pharmaceutical Co., Ltd.'s (TSE:4528) Muted Earnings
Jun 24Ono Pharmaceutical (TSE:4528) Has Announced A Dividend Of ¥40.00
Mar 04Is There An Opportunity With Ono Pharmaceutical Co., Ltd.'s (TSE:4528) 42% Undervaluation?
Feb 27CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | JP¥95b |
| Jun 30 2024 | n/a | n/a | JP¥121b |
| Mar 31 2024 | JP¥190m | JP¥78m | JP¥128b |
| Dec 31 2023 | n/a | n/a | JP¥128b |
| Sep 30 2023 | n/a | n/a | JP¥125b |
| Jun 30 2023 | n/a | n/a | JP¥115b |
| Mar 31 2023 | JP¥228m | JP¥77m | JP¥113b |
Compensation vs Market: Gyo's total compensation ($USD1.23M) is about average for companies of similar size in the JP market ($USD1.04M).
Compensation vs Earnings: Gyo's compensation has been consistent with company performance over the past year.
CEO
Gyo Sagara (66 yo)
16.2yrs
Tenure
JP¥190,000,000
Compensation
Mr. Gyo Sagara has been the Chief Executive Officer at Ono Pharmaceutical Co., Ltd since April 01, 2024 and serves as it’s Director and served as its President since September 2008 until April 01, 2024 and...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman of the Board | 16.2yrs | JP¥190.00m | 0.026% ¥ 206.1m | |
| President | less than a year | no data | 0.0092% ¥ 73.8m | |
| Corp. Offcr. and Div. Dir. of Corp. Strategy & Planning | 1.3yrs | no data | no data | |
| Corporate Officer & Head of Risk and Compliance Management Department | 1.8yrs | no data | no data | |
| Corporate Executive Off. and Exe. Dir. of Sales | no data | no data | no data | |
| Corporate Officer & Head of Business Strategy Headquarters | 1.8yrs | no data | no data | |
| Ex. EO, Exe. Dir. of Sus. Promotion Corp. Strategy | 1.8yrs | no data | 0.0060% ¥ 48.1m | |
| Corporate Officer & Deputy Executive Director | no data | no data | no data | |
| Corporate Officer & Head of Medical Affairs | no data | no data | no data | |
| Corporate Executive Officer | no data | no data | no data | |
| Head of Development Div. | no data | no data | no data |
1.8yrs
Average Tenure
60yo
Average Age
Experienced Management: 4528's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Chairman of the Board | 18.4yrs | JP¥190.00m | 0.026% ¥ 206.1m | |
| President | 4.4yrs | no data | 0.0092% ¥ 73.8m | |
| Ex. EO, Exe. Dir. of Sus. Promotion Corp. Strategy | 4.4yrs | no data | 0.0060% ¥ 48.1m | |
| Independent Outside Director | 3.4yrs | no data | no data | |
| Outside Audit & Supervisory Board Member | 4.4yrs | no data | no data | |
| Outside Audit & Supervisory Board Member | 8.4yrs | no data | no data | |
| Audit & Supervisory Board Member | less than a year | no data | 0.0032% ¥ 25.7m | |
| Independent Outside Director | 6.4yrs | no data | no data | |
| Independent Outside Director | 4.4yrs | no data | no data | |
| Chairman of Audit Supervisory Board | 3.4yrs | no data | 0.00043% ¥ 3.5m |
4.4yrs
Average Tenure
60yo
Average Age
Experienced Board: 4528's board of directors are considered experienced (4.4 years average tenure).